Our products
DSM portfolio of innovative biomedical materials and process manufacturing technologies: Biomedical Polyethylenes, Biomedical polyurethanes, Collagen Technology, Device Development, and Extracellular Matrix (ECM) Technology. Learn more.
Serving the Medical Device Industry for over 30 years
Serving the Medical Device Industry for over 30 years
- History 1
- History 2
Strong history of biomedical innovation and partnering
| 2018 | Aerie Pharmaceuticals and DSM expand collaboration agreement focused on novel drug delivery technology in ophthalmology |
| 2017 | Dyneema Purity® Black fiber |
| Actamax FDA approval to begin pivotal clinical trial for Actamax™ Adhesion Barrier | |
| 2016 | 510(k) approval Porcine Pericardium Devices |
| 2015 | Dyneema Purity® Radiopaque Cerclage Cable FDA 510(k) clearance |
| 2014 | In-house medical coating service plant US Dyneema Purity® fiber plant |
| Dyneema Purity® 10 dtex fiber and Radiopaque fiber | |
| PRP Device FDA 510(k) clearance | |
| Cellular therapy development services | |
| 2013 | Meso Bilayer Surgical Mesh FDA 510(k) clearance |
| UHMWPE membrane technology | |
| 2012 | Kensey Nash Acquisition |
| Porcine Mesothelium Devices | |
| 2011 | Actamax DSM-DuPont JV |
| HQ move to US | |
| Settable Fiber Reinforced CPC BVFs | |
| Porous Beta-TCP Preform BVFs | |
| 2010 | Expanded portfolio for ophthalmic applications |
| 2009 | Medivas technology acquisition for Drug Delivery |
| Bionate® II PCU | |
| Next generation UH product | |
| VitroStealth® non-biofouling coatings | |
| Dental membrane | |
| Porcine Dermis Devices | |
| 2008 | Acquisition of The Polymer Technology Group |
| Cardiovascular drug delivery development partnership | |
| Dyneema Purity® fiber for cardiovascular and spinal applications | |
| 2007 | Thrombectomy Catheters |
| 2006 | First sales Medical Coatings |
| Start of UH and drug delivery activities | |
| BMM Public Private Partnership funded by Dutch government | |
| Surgical Tools | |
| Cartilage Repair | |
| 2005 | Biomedical EBA launched |
| 2004 | Dyneema Purity® fiber for knee ligament fixation |
| Oriented Self Reinforced Polymer Devices | |
| 2003 | Dyneema Purity® orthopedic sutures |
| 2002 | Medical Coating R&D efforts started in DSM Desotech |
| 2000 | Degradable foamed polymer devices |
| Collagen components | |
| DSM Dyneema’s medical R&D efforts |
Our purpose is to create brighter lives for all
30K+
Over 30,000 ECM
devices implanted
100K+
Over 100,000 synthetic bone
grafts manufactured per year
30+
Serving the Medical Device
Industry for over 30 years
Biomedical Brochure
DSM in biomedical: Advanced biomedical solutions to improve lives.
Read more
-
-
The markets we serve
DSM Biomedical offers the broadest portfolio of biomedical materials and manufacturing across market applications, including orthopedics, ophthalmology, neurology, cardiology, diabetes, wound, and continence care.
-
The services we provide
Excelling in medical device partner services, DSM Biomedical supports our customers end-to-end.